33 results
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
20 Mar 24
RepliCel announces a Letter of Intent for Asset Purchase Agreement
4:38pm
Exchange ("TSXV") and seek minority shareholder approval for a voluntary delisting of RepliCel's common shares from the facilities of the TSXV … by Andrew Schutte for common shares held either directly or indirectly in accordance with Multilateral Instrument 61-101 - Protection of Minority
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
20 Mar 24
RepliCel announces a Letter of Intent for Asset Purchase Agreement
4:38pm
with the Proposed Transaction, RepliCel will also submit an application with the TSX Venture Exchange ("TSXV") and seek minority shareholder approval … in accordance with Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"), as further
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
18 May 23
RepliCel Applies to Extend Warrant and Stock Option Expiry Dates and Announces Grant of Stock Options
1:58pm
to be “related parties” of the Company within the meaning of Multilateral Instrument 61-101 Protection of Minority Security Holders in Special … on a specified market and from the minority shareholder approval requirements of MI 61-101 by virtue of the exemption contained in section 5.7(a) of MI 61-101
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
18 May 23
RepliCel Applies to Extend Warrant and Stock Option Expiry Dates and Announces Grant of Stock Options
1:58pm
of Minority Security Holders in Special Transactions (“MI 61-101”) and each extension is considered to be a “related party transaction” within the meaning … ) as the Company’s shares are not listed on a specified market and from the minority shareholder approval requirements of MI 61-101 by virtue of the exemption
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
25 Oct 22
Current report (foreign)
12:27pm
participation by insiders in the Offering will constitute a related party transaction under Multilateral Instrument 61-101 - Protection of Minority Security … Holders in Special Transactions (“MI 61-101”) but is expected to be exempt from the formal valuation and minority shareholder approval requirements
6-K
EX-99.1
suwmi h4jtzm1
6 Sep 22
RepliCel Announces Non-brokered Private Placement
2:35pm
6-K
EX-99.4
0fllqd3twi6tl
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.5
bja2ipv 8iikhqfatlk
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.3
pe9oe1iks07v f1ug
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.2
4kp9t03i4fm
29 Mar 22
RepliCel Announces Non-brokered Private Placement
1:02pm
6-K
EX-99.1
ynudjiv78y5lyxj86iwd
29 Mar 22
RepliCel Announces Non-brokered Private Placement
1:02pm
6-K
EX-99.2
ozv61cx7r iws2
18 Aug 21
RepliCel Life Sciences Announces Closing of Debt Settlement
12:34pm
6-K
EX-99.1
7ewyd
18 Aug 21
RepliCel Life Sciences Announces Closing of Debt Settlement
12:34pm
6-K
EX-99.8
gkw mc2xn4c8ocpp
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.7
h6td3mbtwke zeja5umt
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.1
sgv0b
13 Aug 21
RepliCel Life Sciences Announces Debt Settlement
12:00am
6-K
EX-99.2
mtm41cd73 h2zxf
13 Aug 21
RepliCel Life Sciences Announces Debt Settlement
12:00am
6-K
EX-99.1
pr07dzc n401
13 Aug 21
51-102F3 Material Change Report
12:00am
6-K
EX-99.3
s72zi6pdvqss4
13 Aug 21
RepliCel Life Sciences Announces Debt Settlement
12:00am
6-K
EX-99.2
zi2aw 3i657yie
8 Sep 20
Replicel Announces Extension to Private Placement
7:14pm